(Q34428200)

2 August 2017

title

Alopecia areata: an evidence-based treatment update (English)

1 reference

2 August 2017

1 reference

Maria Hordinsky

1

1 reference

2 August 2017

Aline Donati

series ordinal

2

1 reference

2 August 2017

publication date

1 July 2014

1 reference

American Journal of Clinical Dermatology

2 August 2017

published in

1 reference

2 August 2017

volume

15

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

231-246

1 reference

Treatment of alopecia areata: "What is new on the horizon?".

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: A randomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Pseudo alopecia areata caused by skull-caps with metal pin fasteners used by Orthodox Jews in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

A randomized trial of minoxidil in chemotherapy-induced alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Paroxetine in alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Alopecia areata following adalimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Subcutaneous efalizumab is not effective in the treatment of alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Pulse corticosteroid therapy for alopecia areata: study of 139 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Placebo-controlled oral pulse prednisolone therapy in alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Hypertrichosis induced by latanoprost

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Hair regrowth with topical triiodothyronine ointment in patients with alopecia areata: a double-blind, randomized pilot clinical trial of efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

The Development of Clinical Practice Guidelines and Guidance Statements of the American College of Physicians: Summary of Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0086-4

10.1007/S40257-014-0086-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1027579086

0 references

1 reference